Results 281 to 290 of about 87,487 (309)
Some of the next articles are maybe not open access.
Endocrinology and Metabolism Clinics of North America, 1994
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction and voiding symptoms in elderly men. The pathogenesis is not fully determined but a combination of androgens and age are needed for development of BPH. Symptoms of BPH are divided into obstructive and irritative symptoms but large interpersonal variability is ...
M, Jonler +3 more
openaire +2 more sources
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction and voiding symptoms in elderly men. The pathogenesis is not fully determined but a combination of androgens and age are needed for development of BPH. Symptoms of BPH are divided into obstructive and irritative symptoms but large interpersonal variability is ...
M, Jonler +3 more
openaire +2 more sources
BENIGN PROSTATIC HYPERPLASIA (THE AGING PROSTATE)
Medical Clinics of North America, 1999BPH is a common phenomenon of the aging process. Clinical manifestations may range from minimally bothersome symptoms to urinary retention and renal failure. Tailoring of treatment based on the individual patient is required for successful management. For mild symptoms, watchful waiting is a valid option.
Robert G. Moore +2 more
openaire +3 more sources
CHRONIC PROSTATITIS IN BENIGN PROSTATIC HYPERPLASIA
British Journal of Urology, 2008SUMMARY Gross and histological studies of surgically resected prostate glands and glands recovered at autopsy have shown a close correlation between the type of hyperplasia in the gland and the degree of chronic prostatitis. Three types of hyperplasia are recognised.
E. A. Elebute, E. O. Odunjo
openaire +3 more sources
Clinics in Geriatric Medicine, 2010
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies.
openaire +2 more sources
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies.
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2019
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS). The American Urologic Association Symptom Index is a validated, self-administered tool that is used to diagnose LUTS, guide initial treatment, and assess treatment response.
openaire +2 more sources
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS). The American Urologic Association Symptom Index is a validated, self-administered tool that is used to diagnose LUTS, guide initial treatment, and assess treatment response.
openaire +2 more sources
Urologic Clinics of North America, 1996
This article is devoted to the most common cause of outlet obstruction in the male geriatric population, benign prostate hyperplasia (BPH). The prevalence, pathophysiology, and natural history of BPH is discussed, along with the work-up and indications for medical or surgical intervention.
Jay B. Hollander, Ananias C. Diokno
openaire +3 more sources
This article is devoted to the most common cause of outlet obstruction in the male geriatric population, benign prostate hyperplasia (BPH). The prevalence, pathophysiology, and natural history of BPH is discussed, along with the work-up and indications for medical or surgical intervention.
Jay B. Hollander, Ananias C. Diokno
openaire +3 more sources
The American Journal of the Medical Sciences, 1997
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are described, along with the current therapeutic options for treatment.
openaire +2 more sources
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are described, along with the current therapeutic options for treatment.
openaire +2 more sources
Surgery (Oxford), 2006
Histological evidence of benign prostatic hyperplasia (BPH) develops in most Western men with increasing age, due to a complex interplay of hormonal and dietary influences. Urinary symptoms, in association with prostatic enlargement, affect 25% of the male population, increasing to 43% of the male population aged > 60 years.
Thomas McNicholas, Stephen Mitchell
openaire +2 more sources
Histological evidence of benign prostatic hyperplasia (BPH) develops in most Western men with increasing age, due to a complex interplay of hormonal and dietary influences. Urinary symptoms, in association with prostatic enlargement, affect 25% of the male population, increasing to 43% of the male population aged > 60 years.
Thomas McNicholas, Stephen Mitchell
openaire +2 more sources
Benign Prostate Hyperplasia and Prostatic Tumor
2013Rising life expectancy has swollen the ranks of men of middle age and beyond. These individuals have a 43 % risk of symptoms of benign prostatic hyperplasia (BPH) and a 9 % chance of being diagnosed with prostate cancer. Although not always life-threatening, prostate diseases are often associated with a significant reduction in quality of life not only
Massimo Valentino +6 more
openaire +3 more sources
Terazosin for benign prostatic hyperplasia
Cochrane Database of Systematic Reviews, 2000Lower urinary tract symptoms associated with benign prostatic obstruction (BPO) occur in up to 70% of men over the age of 60 years. To relieve these bothersome symptoms, treatment options include alpha-antagonists, also know as alpha-blockers.We conducted a systematic review to evaluate the effectiveness and adverse effects of the alpha-blocker ...
Indy Rutks +3 more
openaire +5 more sources